Published in Hepatitis Weekly, April 29th, 2002
"Our top priority is ensuring a safe and available blood supply for the patients we serve," said Dr. Jerry Squires, vice president and chief scientific officer. "This technique further builds upon today's extremely safe blood supply. NAT is another layer of safety that helps assure patients they receive the safest possible products."
In March 1999, the American Red Cross...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.